V

Vaxart

D
VXRT
USD
0.0125
(1.7576%)
Market Closed
9,040.00
Volume
-0.39
EPS
-
Div Yield
-1.608222
P/E
164,597,816.34
Market Cap
Today
1.7576%
1 Week
-5.176%
1 Month
-10.654%
6 Months
-3.339%
12 Months
-1.255%
Year To Date
27.322%
All Time
-99.688%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
MRNA
MRNA
-0.985
(-1.921%)
USD
PFE
PFE
0.135
(0.4941%)
USD
B
BNTX
0.99
(0.9269%)
USD
N
NVAX
0.23
(2.5713%)
USD
I
INO
-0.18
(-3.1524%)
USD
C
CODX
-0.035
(-2.8926%)
USD
V
VIR
-0.385
(-3.7894%)
USD
A
APDN
0.0082
(4.4932%)
USD
VRTX
VRTX
9.22
(1.869%)
USD
REGN
REGN
8.505
(1.0417%)
USD
AZN
AZN
0.835
(1.308%)
USD

Title:
Vaxart

Sector:
Healthcare
Industry:
Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Do you need help or have a question?
Contact Us